Clinical trials
Active, not recruiting Neoplasms trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 3 |
| AstraZeneca | 2 |
| Norwegian Institute of Public Health | 2 |
| Norwegian University of Science and Technology | 2 |
| Bristol-Myers Squibb | 1 |
| Inland Norway University of Applied Sciences | 1 |
| Pfizer | 1 |
| Tesaro, Inc. | 1 |
| Åslaug Helland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 14 |
| Colorectal Neoplasms | 3 |
| Adenoma | 2 |
| Breast Diseases | 2 |
| Breast Neoplasms | 2 |
| Melanoma | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms by Site | 2 |
| Alzheimer Disease | 1 |
| Cachexia | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.